Physician profile
Patrick E Stout
NPI 1366415234
$1,078.89
in general payments reported to CMS, 2019-2025
11 companies · $43.05 in 2025
The $43.05 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $25.73 · 2021: $370 · 2022: $374 · 2023: $74.65 · 2024: $37.73 · 2025: $43.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $364.48 | 2019-2022 | |
| Teleflex LLC | $278.75 | 2021-2025 | Urolift |
| Urovant Sciences INC | $167.66 | 2021-2022 | |
| Abbvie INC. | $74.72 | 2021-2023 | Botox |
| Allergan, INC. | $63.92 | 2020-2022 | |
| Pfizer INC. | $39.40 | 2019-2023 | |
| Tolmar Pharmaceuticals, INC. | $20.70 | 2021 | |
| Coloplast Corp | $20.17 | 2024 | |
| Olympus America INC. | $18.44 | 2025 | Itind System |
| Medtronic, INC. | $17.56 | 2024 | Interstim |
| Neotract INC. | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.